Impact of Patient Age on Postoperative Short-Term and Long-Term Outcome after Pancreatic Resection of Pancreatic Ductal Adenocarcinoma.
age
disease-free survival
elderly
overall survival
pancreatic ductal adenocarcinoma
pancreatic resection
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Aug 2022
15 Aug 2022
Historique:
received:
14
07
2022
revised:
04
08
2022
accepted:
09
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
(1) Purpose: to evaluate the impact of age on postoperative short-term and long-term outcomes in patients undergoing curative pancreatic resection for PDAC. (2) Methods: This retrospective single-center study comprised 213 patients who had undergone primary resection of PDAC from January 2000 to December 2018 at the University Hospital of Erlangen, Germany. Patients were stratified according the age into two groups: younger (≤70 years) and older (>70 years) patients. Postoperative outcome and long-term survival were compared between the groups. (3) Results: There were no significant differences regarding inhospital morbidity (58% vs. 67%, p = 0.255) or inhospital mortality (2% vs. 7%, p = 0.073) between the two groups. The median overall survival (OS) and disease-free survival (DFS) were significantly shorter in elderly patients (OS: 29.2 vs. 17.1 months, p < 0.001, respectively; DFS: 14.9 vs. 10.4 months, p = 0.034). Multivariate analysis revealed that age was a significant independent prognostic predictor for OS and DFS (HR 2.23, 95% CI 1.58−3.15; p < 0.001 for OS and HR 1.62, 95% CI 1.17−2.24; p = 0.004 for DFS). (4) Conclusion: patient age significantly influenced overall and disease-free survival in patients with PDAC undergoing primary resection in curative intent.
Identifiants
pubmed: 36010922
pii: cancers14163929
doi: 10.3390/cancers14163929
pmc: PMC9406071
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Surg Oncol. 2017 Oct;24(11):3220-3228
pubmed: 28695390
World J Oncol. 2019 Feb;10(1):10-27
pubmed: 30834048
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):353-363
pubmed: 28823364
Front Oncol. 2022 Mar 31;12:789351
pubmed: 35433408
J Gastrointest Oncol. 2015 Oct;6(5):498-504
pubmed: 26487943
Surgery. 2005 Jul;138(1):8-13
pubmed: 16003309
J Hepatobiliary Pancreat Surg. 2009;16(5):675-80
pubmed: 19387530
Nutrients. 2021 May 22;13(6):
pubmed: 34067286
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Br J Surg. 2014 Jul;101(8):1000-5
pubmed: 24844590
Arch Med Sci. 2020 May 04;16(4):820-824
pubmed: 32542083
World J Gastroenterol. 2016 Jan 14;22(2):764-75
pubmed: 26811623
Eur J Surg Oncol. 2013 Feb;39(2):171-8
pubmed: 22999411
Br J Cancer. 2014 Jan 21;110(2):313-9
pubmed: 24263063
Updates Surg. 2019 Dec;71(4):653-657
pubmed: 30673978
JAMA Surg. 2020 Sep 1;155(9):832-839
pubmed: 32667641
J Geriatr Oncol. 2019 Jul;10(4):540-546
pubmed: 30573201
Cancer. 2016 Nov 15;122(21):3378-3385
pubmed: 27419382
Ann Surg. 2006 Dec;244(6):931-7; discussion 937-9
pubmed: 17122618
HPB (Oxford). 2018 Nov;20(11):1051-1061
pubmed: 29887259
J Gastrointest Surg. 2010 Nov;14(11):1826-31
pubmed: 20714937
Gastroenterology. 2021 Feb;160(3):744-754
pubmed: 33058868
Acta Oncol. 2022 Mar;61(3):286-293
pubmed: 34935577
Ann Surg. 2008 Sep;248(3):459-67
pubmed: 18791366
J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):188-97
pubmed: 26763744
Ann Surg. 2016 Dec;264(6):1082-1090
pubmed: 26978570
Surgery. 2007 Jul;142(1):20-5
pubmed: 17629996
J Am Coll Surg. 2015 Apr;220(4):530-6
pubmed: 25724606
J Gastrointest Surg. 2006 Mar;10(3):347-56
pubmed: 16504879
J Gastrointest Surg. 2010 Nov;14(11):1838-46
pubmed: 20824366
J Am Coll Surg. 2007 Dec;205(6):729-34
pubmed: 18035254
Ann Surg Oncol. 2020 Jun;27(6):1997-2006
pubmed: 31894482
Eur J Cancer. 2021 Feb;144:81-90
pubmed: 33341449
Pancreas. 2016 Nov;45(10):1411-1417
pubmed: 27171511
Surgery. 2018 Nov;164(5):1035-1048
pubmed: 30029989
Langenbecks Arch Surg. 2013 Apr;398(4):531-8
pubmed: 23462741